Membrane-anchored peptide inhibits human immunodeficiency virus entry

Journal of Virology

Volumn 75, Issue 6, 2001, Pages 3038-3042

  Hildinger, M ^a   Dittmar, M T ^a   Schult Dietrich, P ^a   Fehse, B ^a   Schnierle, B S ^a   Thaler, S ^a   Stiegler, G ^a   Welker, R ^a   Von Laer, D ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENFUVIRTIDE; GLYCOPROTEIN GP 41; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE THERAPY; GENETIC TRANSDUCTION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS CELL INTERACTION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL LINE; CELL MEMBRANE; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RETROVIRIDAE; T-LYMPHOCYTES, HELPER-INDUCER; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 0035120510     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.6.3038-3042.2001     Document Type: Article

References (30)

1. Generation of human monoclonal antibodies against HIV-1 proteins: Electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
2. Core structure of gp41 from the HIV envelope glycoprotein
3. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
4. High-titer packaging cells producing recombinant retroviruses resistant to human serum
5. Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
6. Selective immuno-affinity-based enrichment of CD34+cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene
7. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
8. Capture of an early fusion-active conformation of HIV-1 gp41
9. In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency vires capsid proteins in the presence and absence of cyclophilin A
10. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein
11. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
12. Dominant selection of human progenitor cells with retroviral mdr-1-coexpression vectors
13. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
14. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro
15. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity
16. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41
17. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
18. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase
19. + T-cell clone (PM-1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-I
20. Signal sequences: More than just greasy peptides
21. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation
22. A stable human-derived cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
23. Determinants of human immunodeficiency virus type I resistance to gp41-derived inhibitory peptides
24. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
25. Inhibition of human immunodeficiency type I replication in human cells stably expressing antisense RNA
26. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes
27. Gene therapy for AIDS
28. Atomic structure of the ectodomain from HIV-1 gp41
29. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: Analysis of its role in enhancement of viral infectivity
30. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection